Benjamin A Lipsky Selected Research

Diabetic Foot

1/2022	Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days.
1/2022	Short and oral antimicrobial therapy for diabetic foot infection: a narrative review of current knowledge.
1/2022	Treatment Failures in Diabetic Foot Osteomyelitis Associated with Concomitant Charcot Arthropathy: The Role of Underlying Arteriopathy.
10/2021	Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomized, Noninferiority Pilot Trial.
1/2021	Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection?
1/2021	How good are clinicians in predicting the presence of Pseudomonas spp. in diabetic foot infections? A prospective clinical evaluation.
11/2020	The dynamic wound microbiome.
1/2020	Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update).
1/2020	Diagnosing diabetic foot osteomyelitis.
1/2020	Interventions in the management of infection in the foot in diabetes: a systematic review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin A Lipsky Research Topics

Disease

84	Infections 01/2022 - 06/2002
64	Diabetic Foot 01/2022 - 05/2004
39	Wounds and Injuries (Trauma) 11/2020 - 06/2004
26	Osteomyelitis 01/2022 - 01/2004
20	Ulcer 11/2020 - 05/2004
8	Foot Ulcer 01/2018 - 01/2004
5	Soft Tissue Infections 01/2022 - 02/2005
5	Diabetes Mellitus 09/2019 - 01/2007
4	Abscess 01/2018 - 06/2004
4	Wound Infection (Wound Infections) 04/2017 - 02/2005
4	Sepsis (Septicemia) 11/2004 - 06/2002
3	Alcoholism (Alcohol Abuse) 01/2022 - 10/2013
3	Gangrene 01/2018 - 06/2004
3	Necrotizing Fasciitis 01/2018 - 06/2004
3	Obesity 04/2017 - 10/2013
3	Cellulitis 09/2012 - 11/2007
3	Bacteriuria 06/2010 - 07/2006
2	Neoplasms (Cancer) 01/2022 - 09/2006
2	Ischemia 01/2020 - 06/2006
2	Communicable Diseases (Infectious Diseases) 11/2016 - 12/2015
2	Surgical Wound Infection 09/2012 - 11/2007
2	Bacteremia 08/2010 - 09/2006
2	Cross Infection (Nosocomial Infection) 08/2010 - 11/2007
1	Fibrosis (Cirrhosis) 01/2022
1	Diabetes Complications 11/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Hyperglycemia 01/2018
1	Joint Diseases (Joint Disease) 01/2018
1	Complex Regional Pain Syndromes 01/2018
1	Osteoarthritis 01/2018
1	Pain (Aches) 01/2018
1	Surgical Wound 04/2017
1	Bursitis (Adhesive Capsulitis) 01/2017
1	Reinfection 01/2016
1	Healthcare-Associated Pneumonia 01/2016
1	Burns 12/2015

Drug/Important Bio-Agent (IBA)

73	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2004
7	Ertapenem (Invanz)FDA Link 01/2020 - 06/2004
6	Anti-Infective Agents (Microbicides)IBA 01/2017 - 09/2007
5	Vancomycin FDA LinkGeneric 01/2016 - 02/2005
4	Penicillins (Penicillin)FDA Link 01/2021 - 02/2005
4	C-Reactive ProteinIBA 01/2021 - 12/2006
4	Linezolid (Zyvox)FDA Link 01/2016 - 01/2004
4	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 08/2013 - 02/2005
4	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 09/2007 - 11/2005
3	Tigecycline (Tygacil)FDA Link 01/2020 - 11/2010
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2019 - 01/2004
3	Amoxicillin (Wymox)FDA LinkGeneric 01/2019 - 01/2004
3	Gentamicins (Gentamicin)FDA LinkGeneric 01/2018 - 05/2012
3	CollagenIBA 01/2018 - 05/2012
3	Daptomycin FDA Link 09/2015 - 02/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2013 - 02/2005
2	Second Generation CephalosporinsIBA 01/2021 - 09/2015
2	Ointments (Pastes)IBA 01/2020 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 03/2018 - 01/2018
2	beta Lactam AntibioticsIBA 03/2018 - 09/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 09/2006
2	Epidermal Growth Factor (EGF)IBA 11/2017 - 01/2017
2	Local Anti-Infective Agents (Antiseptics)IBA 01/2017 - 01/2016
2	beta-Lactamase InhibitorsIBA 09/2015 - 01/2004
2	Carbapenems (Carbapenem Antibiotics)IBA 09/2015 - 06/2004
2	Clindamycin (Cleocin)FDA LinkGeneric 09/2015 - 05/2005
2	FluoroquinolonesIBA 09/2015 - 12/2008
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 12/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2013 - 07/2009
2	Moxifloxacin (Avelox)FDA Link 11/2010 - 08/2007
2	Pharmaceutical PreparationsIBA 05/2007 - 01/2004
2	SolutionsIBA 09/2003 - 06/2002
2	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 09/2003 - 06/2002
2	Povidone-Iodine (Betadine)FDA LinkGeneric 09/2003 - 06/2002
1	Oxygen (Dioxygen)IBA 01/2020
1	Floxacillin (Flucloxacillin)IBA 01/2020
1	5'-N-methylcarboxamideadenosineIBA 03/2018
1	SilverIBA 01/2016
1	IodineIBA 01/2016
1	PlasticsIBA 12/2015
1	acivicin (AT 125)IBA 12/2015

Therapy/Procedure

74	Therapeutics 01/2022 - 05/2004
35	Surgical Amputation (Amputations) 01/2022 - 05/2004
20	Debridement 01/2022 - 06/2004
6	Catheters 02/2012 - 06/2002
5	Duration of Therapy 01/2019 - 11/2010
5	Operative Surgical Procedures 01/2016 - 06/2004
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2010
3	Negative-Pressure Wound Therapy 01/2020 - 12/2015
3	Length of Stay 01/2017 - 11/2007
3	Glycemic Control 12/2015 - 09/2013
2	Prostheses and Implants (Prosthesis) 08/2010 - 11/2007
2	Hyperbaric Oxygenation 05/2010 - 06/2006
2	Curettage 09/2007 - 06/2006
2	Central Venous Catheters 11/2004 - 05/2004
2	Vascular Access Devices (Arterial Line) 09/2003 - 06/2002
1	Renal Dialysis (Hemodialysis) 01/2022
1	Organ Transplantation 01/2022
1	Arthrodesis 01/2018
1	Operative Time 04/2017
1	Aftercare (After-Treatment) 01/2016
1	Replacement Arthroplasty 12/2015
1	Fracture Fixation 12/2015